Covering emerging trends (such as blockchain, cannabis, and artificial intelligence) as well as stalwarts (pharma, pharma, pharma), here is a quick look at some of the most well-read patents-focused writing published on JD Supra during this year. Good work, smart folks.
Popular Patents Reads on JD Supra, 2019
- When Innovation Invents: Artificial Intelligence Issues at the U.S. Patent and Trademark Office - by Emily Tait, Carl Kukkonen III, and Eli Temkin at Jones Day
- Blockchain Goes Wall Street – New Issued Patent Covers Cryptocurrency Trading Platform - by Ahmed Abdel-Rahman at Pillsbury
- CRISPR Patent Watch - by Kevin Noonan at MBHB
- ANDA Approvals - Spring 2019 - by attorneys at Robins Kaplan
- AI Patent Policy - by Anna Yuan, Karen Potter, and Amanda Elisabeth Casale at Morrison & Foerster
- Intellectual Property Law Year in Review - March 2019 - by Nicole Jantzi at McDermott Will & Emery
- Patenting Trends - by Kate Gaudry Ph.D. and Thomas Franklin at Kilpatrick Townsend
- Amerigen Pharmaceuticals v. UCB Pharma GMBH - by Bita Kianian, Paul Stewart, and Nicole Townes at Knobbe Martens
- Yes, UCANN! - by Yasamin Parsafar at Sheppard Mullin
- Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2019) - by Donald Zuhn at MBHB
- Popular Open Source Software under Patent Attack - by James Gatto at Sheppard Mullin
- NICE Files Patent Lawsuit against CallMiner over Cloud-Based Speech Analytics, Call Monitoring, and Data Security Technology Solutions - by Jonathan Barnard at Shook, Hardy & Bacon
- Coherus Settles with AbbVie, and Sues Amgen, Over Adalimumab Biosimilars (Updated) - by attorneys at Goodwin
*
For a deeper dive into patent trends right now, ask us about access to Beacon Insights dashboards.